Cesca Therapeutics’ Indian Subsidiary Expands Cord Blood Banking Services To Additional Hospitals In The Fortis Healthcare Network
March 30, 2016 06:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 30, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that its wholly-owned...
Cesca Therapeutics Appoints Vascular Surgery Expert Lars Norgren, M.D., Ph.D., to its Clinical Advisory Board
March 23, 2016 06:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 23, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Dr. Lars Norgren, MD,...
Cesca Therapeutics to Present at the ARM 4th Annual Cell & Gene Therapy Investor Day
March 16, 2016 06:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 16, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Mike Bruch, Cesca...
Cesca Therapeutics Appoints Dr. Xiaochun Xu, Chairman and CEO of Boyalife Group, to Board of Directors
March 10, 2016 06:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 10, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Dr Xiaochun Xu (44)...
Cesca Therapeutics Announces 1-for-20 Reverse Split of Common Stock
March 04, 2016 16:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 04, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, has amended its Certificate of...
Cesca Therapeutics Announces 1-for-20 Reverse Split of Common Stock
March 02, 2016 16:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 02, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced stockholder approval of a...
Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results and Provides a Status Update to Investors
February 16, 2016 16:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL) (the “Company”), an autologous cell-based regenerative medicine company, today reported financial...
Cesca Therapeutics to Announce Second Quarter Fiscal 2016 Results and Provide a Status Update to Investors on February 16, 2016
February 11, 2016 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that it will report...
Texas Stem Cell Enters Into an Agreement With Cesca Therapeutics for Use of AutoXpress® Technology for Cord Blood Processing
February 09, 2016 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif. and HOUSTON, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Texas Stem...
Cesca Announces $15 Million Strategic Investment From Boyalife Group
February 03, 2016 09:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that affiliates of Boyalife...